SCHEMBL13829862

SCHEMBL13829862

NC(=O)OC1COC1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20118545 0.90 ATM (0.41)
SCHEMBL28716747 0.83 ATM (0.39)
SCHEMBL29042319 0.83 ATM (0.36)
SCHEMBL19558723 0.81
SCHEMBL22356126 0.81
SCHEMBL2239226 0.81
SCHEMBL4566630 0.78 ATM (0.36)
SCHEMBL21873698 0.77 ATM (0.47)
SCHEMBL9804253 0.76
SCHEMBL2285843 0.76

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 19 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3619204-B1 COMPOUNDS FOR THE TREATMENT OF RESPIRATORY DISEASES TIANLI BIOTECH PTY LTD (AU) 2025-10-01 EP disclosed
EP-4568959-A1 BICYCLIC TETRAHYDROTHIAZEPINE DERIVATIVES F. Hoffmann-La Roche AG (CH) 2025-06-18 EP disclosed
CN-114514023-B Methods of treating pancreatic cancer using RAD51 inhibitors 赛泰尔治疗公司 2025-01-14 CN disclosed
CN-119285628-A Compounds for the treatment and prophylaxis of respiratory syncytial virus infection diseases 石药集团中奇制药技术(石家庄)有限公司 2025-01-10 CN disclosed
CN-118852149-A Compound for treating or preventing RSV virus diseases 石药集团中奇制药技术(石家庄)有限公司 2024-10-29 CN disclosed
US-20240317724-A1 3,4-METHYLENEDIOXYMETHAMPHETAMINE AND RELATED PSYCHEDELICS AND USES THEREOF TERRAN BIOSCIENCES INC (US) 2024-09-26 US disclosed
CN-117897149-A 3, 4-methylenedioxymethamphetamine and related hallucinogens and uses thereof 人类生物科学股份有限公司 2024-04-16 CN disclosed
CN-111542521-B RAD51 inhibitors 赛泰尔治疗公司 2024-02-23 CN disclosed
WO-2024017358-A1 MACROCYCLIC COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF, AND USE THEREOF 贝达药业股份有限公司 2024-01-25 WO disclosed
CN-117120429-A KHK inhibitor 吉利德科学公司 2023-11-24 CN disclosed
WO-2023081312-A1 SMALL MOLECULE INDUCERS OF AUTOPHAGY Vir Biotechnology, Inc. (US) 2023-05-11 WO disclosed
US-20220380343-A1 COMPOUNDS FOR THE TREATMENT OF RESPIRATORY DISEASES TIANLI BIOTECH PTY LTD (AU) 2022-12-01 US disclosed
CN-114072390-A RAD51 inhibitors 赛泰尔治疗公司 2022-02-18 CN disclosed
US-20200079757-A1 COMPOUNDS FOR THE TREATMENT OF RESPIRATORY DISEASES THE UNIVERSITY OF MELBOURNE (AU) 2020-03-12 US disclosed
EP-3619204-A1 COMPOUNDS FOR THE TREATMENT OF RESPIRATORY DISEASES The University of Melbourne (AU) 2020-03-11 EP disclosed
WO-2019079649-A1 SUBSTITUTED PYRROLOPYRIDINES AS INHIBITORS OF ACTIVIN RECEPTOR-LIKE KINASE BLUEPRINT MEDICINES CORPORATION (US) 2019-04-25 WO disclosed
WO-2018201192-A1 COMPOUNDS FOR THE TREATMENT OF RESPIRATORY DISEASES THE UNIVERSITY OF MELBOURNE (AU) 2018-11-08 WO disclosed
EP-2704246-A1 NON-AQUEOUS ELECTROLYTIC SOLUTION, ELECTRICAL STORAGE DEVICE UTILIZING SAME, AND CYCLIC SULFONIC ACID ESTER COMPOUND Ube Industries, Ltd. (JP) 2014-03-05 EP disclosed
WO-2012151195-A1 HEPATITIS C VIRUS INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 2012-11-08 WO disclosed